PAR-21-059 - Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Expired NOSIs
| Title | Notice Number | Organization | Release Date | Expiration Date | Activity Code(s) |
|---|---|---|---|---|---|
| Notice of Special Interest: Biomarker Discover and Validation in Functional Neurological Disorders | NOT-NS-22-010 | NINDS | Oct 1, 2021 | Jan 8, 2025 | R61/R33, U01, U44 |
For technical issues E-mail OER Webmaster